I. IUCHI of substrate and finally 3) release of free enzyme. Abnormal PsChE has reduced activity and is less inhibited by inhibitors because the abnormal PsChE has about 100-fold lower affinity for substrate Or inhibitors than the usual enzyme (Kalow, 1959) . Therefore, PsChE variants are subtyped by such characteristics as reduced activity and percentage inhibition, called the inhibition number--dibucaine number (DN), fluoride number (FN), chloride number (CN), and others (see below).
A new colorimetric method which has proved to be accurate and useful for subtyping and mass-screening of serum was established by us after careful examination of the methods of Kalow and Lindsay (Kalow and Lindsay, 1955) and Harris and Whittaker (Harris and Whittaker, 1961) 13 years ago (Iuchi, 1969a) . This method uses butyrylcholine as substrate and DTNB for coloration of thiocholine, a hydrolysis product of the substrate.
Many competitive and denaturing agents have been introduced as suitable inhibitors for PsChE phenotyping (Whittaker, 1980) , such as dibucaine (D), sodium fluoride (F), sodium chloride (C1), butanol (Alc), pancronium (P), scoline (= suxamethonium) (S), urea (U), sodium bromide (Br), Rosche's agent of and propranolol (Pr) . Of the inhibitors aforelisted, the first two substances (D, F) are the main subtyping agents based on the structural aberrancy of the PsChE molecule, since they interact with the substrate at the anionic and ester sites of the enzyme molecule, respectively. The other compounds might be considered as auxilliarly agents for identification of D and F anomalies.
It was felt that the measurement of various inhibition numbers and their inhibition curves as well as family study were essential for phenotyping each PsChE anomaly.
Genetics of PsChE and case reports
The E 1 gene locus which is responsible for the production of PsChE has been assigned to chromosome 1 and is sandwiched between the gene for transferrin and phosphogluconate dehydrogenase (Chautard-Freire-Maia, 1977) . Four alMic genes functioning at the same locus E1 have been recognized: the usual gene E~ ~, the atypical or dibucaine resistant gene E1 a, the fluoride resistant gene E1 f and the anenzymic also called silent gone E1 s. These gone give rise to ten phenotypes. The homozygotes and double heterozygote in the various combinations involving E1 a, E1 f, and E1S (6 in all) invariably exhibit moderate to severe SCC hypersensitivity. Other rare genes designated as EI~, E1 k, C1 d, E1 ale have also been reported in the heterozygous condition (Whittaker, 1980) . The first instance of PsChE anomaly in Japan was discovered by us in 1967 in a 62 yr-old male patient with hypertension and encephalomalacia (Shibata et al., 1967) . All his biochemical hepatic function tests except for PsChE were within normal range and he had no neoplasms or inflammatory lesions. His PsChE activity were almost zero around, being 2~o .of normal throughout the observation periods over one and a half years. Family study indicated a cluster of consanguineous The individuals shown as IV-5 and V-6 were presumed to have the same common ancestor of unknown generations with proband's family since they originated at the same village. Three homozygotes with ElsE1 s, one double heterozygotes with E~sE1 f and ten heterozygotes with E~uE~ s were detected in this family. The individual shown as VI-4 in the family tree was a 4 months old baby at first time examination of 13 years ago. Last year, we were happened to perform a follow up study which confirmed the results with those found previously.
The propositus of the second family, discovered in 1969, was a 3 yr-old giri patient weighing 12.5 kg with cystinuria ( Fig. 1-2) (Iuchi, 1969b) . She was admitted to the Kurashiki Central Hospital for removal of nephro-and ureteroliths. When a dose of 10 mg of SCC was given as a preliminary step in anesthesia for her left ureterolithitomy, an unexpected prolonged apnea lasting 230 rain occurred; her serum specimen was sent to our laboratory, which showed in retrospect that her PsChE activity was completely absent. The second operation for her right pyelolithitomy was performed without using SCC and no prolonged apnea occurred.
Family study revealed seven l)eterozygotes with E~uE~ s and this PsChE anomaly was independent from cystinuria since gene segregation of the two anomalies. was clearly observed.
The third case was a 50 yr-old house wife with slight gastritis (Fig. 1-3 ). The activity of her PsChE was completely absent indicating she was homozygous for the: silent gene. Family study demonstrated two other silent gene homozygotes and three heterozygotes. All these family members, except the proband, were apparently healthy.
Since the first discovery of the aberrant PsChE 13 years ago, thirteen families in total have been studied and phenotyped as shown in Fig. 1 . It was evident that the clinical symptoms complained of by the patient at the time of admission showed no relation to the presence of the PsChE anomaly. They seemed to be distributed sporadically all over Japan, and all the families except for No. 13 were the silent gene type. Homozygotes for the Ex a or E1 f gene, which are significantly distributed among the Europeans, still remain undiscovered in Japan. The types of PsChE deficiency have been differentiated by Type I (O type deficiency) and Type !I (presence of trace amounts of enzyme, T type) which are defined by Rubinstein (Rubinstein, 1970 ) and Scott (Scott, 1973) . Our families, numbers 2, 3, 4, 5, 8, 9, 11 and 12 are classified as Type I and families 1, 6, 7 and I0 as Type II. These classifications of the families were supported by the isozyme staining of PsChE on polyacrylamide slab gel electrophoresis (pH 8.0) and immunologic assay by Ouchterlony's double diffusion technics. The type I anomaly were truely anenzymic with complete disappearance of C1, C~, Ca and Ca components which are usually seen in normal sera, while the Type II anomalies revealed 2-10~ activity, and showed a faintly stained Ca band.
The other type of PsChE anomaly was a patient exhibiting unusually high PsChE activity with evidence of its heredity transmission shown in Fig. 1-13 . The proband was a 32 H-old male patient with paralysed lower extremities because of head injury at age of 3. The mother was also a carrier without any other abnormalities in her blood chemistry examination and was apparently healthy. The proband's PsChE activity was four times higher than normal. DN and FN were normal. Isozyme study demonstrated an extra band between C4 and C5 band. The biochemical characteristics of this enzyme were similar to the Cynthiana type PsChE anomaly described by Yoshida (Yoshida and Motulsky, 1969) . As for the C5 band, it is electrophoretically seen at the cathodic site of C4 band in some normal persons and the gene responsible for this enzyme is designated as E~, which is located at different position from E1 gene locus. The carrier with this component reveals 10-30~ higher activity than the non-carrier. The carrier of the E~ locus in Japan was estimated by our survey to be about 5~.
The instances of PsChE anomalies reported during the past 14 years in Japan are summarized in Table 1 . It is conjectured that the frequency of the PsChE anomaly in Japan is quite rare compared with those of European countries possibly because of a paucity of publications. Of these reports, individuals detected by SCC hypersensitivity included only two patients of which was our second family. The remaining families have been detected by noticing unusually low activity PsChE which is measured as one of the routine hepatic function tests in the clinical laboratory. Therefore, it might be true the deficiency type of PsChE are more easily detected than the other E1 a or E~ f type since the latter two types necessitate the additional determinations of DN and FN. Accordingly, the frequency of these gene in the order of E15 (Type I)> E~ s (Type II)> E~ a-E~ f in Table 1 may be partially biased.
Population surveys
As preliminary experiments, the activity and the inhibition number by six agents The results of survey of PsChE totaling 1,945 specimens, demonstrated the existence of two and one individuals heterozygous for the E1 f and E1 ~ gene respectively and none homozygous or doubly heterozygous for these gene. This result was practically the same as that of survey which was performed by us 12 years ago in total of 2,050 specimens (Iuchi, 1969a) . From these data combined, the frequency of the E~ f heterozygote was calculated as 1/800 and that of the E1 a heterozygote was 1/4,000. The frequency of silent gene could not be estimated by the screening tests because only the pathological sera were submitted to our laboratory.
A few surveys of PsChE anomaly in Japan have been carried out in the past 14 years. It appears that a total of 7,647 individuals have been screened and ten families with the phenotypes E~uE~ a or EI~E~ f have been detected in an approximate frequency of 0.0018. This result is consistent with the previous conjecture of very rare existence of aberrant PsChE genes in Japan.
However, aberrant genes, particularly the E1 ~ gene, are certainly distributed with smaller but significant frequencies in the Japanese, in contrast to 3-6~ for the E1 a and E~ f genes in Caucasian populations and in Middle East Asians, and 20~ of Et s in the Eskimos of Western Alaska. The elucidation of these differences awaits future study.
